Search Trulicity (type in keywords)
Search Medical Information
If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
TRULICITY® (dulaglutide): QTC Interval
At supratherapeutic doses (4 and 7 mg), dulaglutide does not prolong QTc.
US_cFAQ_GLP054_QTC_INTERVAL
en-US
Detailed Information
The effect of dulaglutide on cardiac repolarization was thoroughly tested in a QTc study and found that at supratherapeutic doses, dulaglutide 4 mg and dulaglutide 7 mg did not prolong QTc.1
Enclosed Prescribing Information
Reference
1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
Glossary
QTc = corrected QT interval
Date of Last Review: January 03, 2020
Are you satisfied with this content?